关注
Lance Munn
Lance Munn
Harvard Medical School
在 steele.mgh.harvard.edu 的电子邮件经过验证 - 首页
标题
引用次数
年份
1295 Systems biology analysis of anti-tumor immunity
M Nikmaneshi, J Baish, T Padera, L Munn
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
2022
577 Cancer immunotherapy responses persist after lymph node resection
H Zhou, MJ O’Melia, JW Baish, LB Darragh, P Lei, L Menzel, JJ Rajotte, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
7. Methicillin-resistant Staphylococcus aureus pathogenicity causes sustained lymphatic dysfunction
D Jones, EFJ Meijer, C Blatter, S Liao, E Pereira, E Bouta, K Jung, ...
Imaging Lymphatics, 106, 2017
2017
897-F Wnt inhibition improves efficacy of immune checkpoint blockade in glioblastoma
S Krishnan, S Lee, Z Amoozgar, S Subudhi, AS Kumar, J Posada, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023
2023
A mathematical framework for predicting oxygen transport and vessel remodeling in tumors
LL Munn, W Kamoun, JA Tyrrell
The FASEB Journal 24, 750.3-750.3, 2010
2010
A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy
BR Stoll, C Migliorini, A Kadambi, LL Munn, RK Jain
Blood 102 (7), 2555-2561, 2003
1592003
A mechanobiological mathematical model of liver metabolism
MR Nikmaneshi, B Firoozabadi, LL Munn
Biotechnology and Bioengineering 117 (9), 2861-2874, 2020
62020
A model for the kinetics of homotypic cellular aggregation under static conditions
S Neelamegham, LL Munn, K Zygourakis
Biophysical journal 72 (1), 51-64, 1997
371997
A multi-scale model for determining the effects of pathophysiology and metabolic disorders on tumor growth
MR Nikmaneshi, B Firoozabadi, A Mozafari, LL Munn
Scientific reports 10 (1), 3025, 2020
162020
A Multiresolution Approach with Method-Informed Statistical Analysis for Quantifying Lymphatic Pumping Dynamics
MS Razavi, KJ Ruscic, EG Korn, M Marquez, TT Houle, D Singhal, ...
bioRxiv, 2024.04. 24.590950, 2024
2024
A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents
RC Jones, DE Capen, KS Cohen, LL Munn, RK Jain, DG Duda
Nature protocols 3 (3), 388-397, 2008
302008
A Self-Assembly Method for Creating Vascularized Tumor Explants Using Biomaterials for 3D Culture
LL Munn, D Bazou
Cancer Cell Culture: Methods and Protocols, 211-220, 2023
2023
A Study of High–Versus Low-Dose-Bevacizumab in Combination with Local Radiotherapy and 5-Flourouracil Chemotherapy in a Phase I Trial for Patients with Locally Advanced Rectal …
CG Willett, Y Boucher, DG Duda, E di Tomaso, LL Munn, RT Tong, L Petit, ...
Aberrant vascular architecture in tumors and its importance in drug-based therapies
LL Munn
Drug discovery today 8 (9), 396-403, 2003
1532003
Abstract A04: Distant lymphoid organs compensate for ICB efficacy after TDLN dissection
H Zhou, M O'Melia, P Lei, JJ Rajotte, MR Razavi, J Baish, LL Munn, ...
Cancer Immunology Research 10 (12_Supplement), A04-A04, 2022
2022
Abstract A64: Mechanistic model for booster doses effectiveness in healthy, cancer and immunosuppressed patients infected with SARS-CoV-2
C Voutouri, CC Hardin, V Naranbhai, MR Nikmaneshi, MJ Khandekar, ...
Cancer Immunology Research 10 (12_Supplement), A64-A64, 2022
2022
Abstract B39: Modulation of cancer immunotherapy by the microbiome: Insights from computational analyses of preclinical studies
C Harkos, A Hadjigeorgiou, AK Mishra, G Morad, S Johnson, NJ Ajami, ...
Cancer Immunology Research 10 (12_Supplement), B39-B39, 2022
2022
Abstract LB-347: Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
J Kloepper, L Riedemann, Z Amoozgar, G Seano, KH Susek, V Yu, ...
Cancer Research 76 (14_Supplement), LB-347-LB-347, 2016
2016
Abstract LB-348: Evolution of physical forces in the tumor microenvironment and implications for therapeutic resistance.
T Stylianopoulos, JD Martin, S Jain, M Snuderl, VP Chauhan, LL Munn, ...
Cancer Research 73 (8_Supplement), LB-348-LB-348, 2013
2013
Abstract LB-363: Inhibition of placental growth factor (PlGF) leads to regression of medulloblastoma
M Snuderl, ND Kirkpatrick, EC Walsh, E Chung, WS Kamoun, ...
Cancer Research 70 (8_Supplement), LB-363-LB-363, 2010
2010
系统目前无法执行此操作,请稍后再试。
文章 1–20